glp-1 receptor agonists and cancer risk in adults with obesity GLP-1s may reduce related risk, new research shows. Across large observational cohorts, they were linked to reduced rates of endometrial, liver, colorectal, other cancers. Learn more at the link Potential Use of GLP-1 and

Available from: Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrm SZ, Davies MJ et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

Forty subjects were divided into a test group (taking four tablets daily) and a placebo group

To test whether the intervention effect differed by age group, a linear mixed model was fitted with TMAO log AUC as the outcome, fixed effects for intervention (placebo vs

SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism

The combination of both CoQ10 and rich antioxidants can support egg quality and fertility outcomes

Instead of simply being a vitamin pill, RegActiv Essential ME-3 is a source of live, active, beneficial bacteria